Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · see citing works

Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen

Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758 · see citing works

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

Ferrante, R. J., Kubilus, J. K., Lee, J.-H., Ryu, H., Beesen, A. A., Zucker, B., Smith, K., Kowall, N. W., Ratan, R. R., Luthi‐Carter, R., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09418.2003 · Cited by 694 · see citing works

Histone Deacetylase Inhibitors Exhibit Anti-Inflammatory and Neuroprotective Effects in a Rat Permanent Ischemic Model of Stroke: Multiple Mechanisms of Action

Kim, H. J., Rowe, M. K., Ren, M., Hong, J., Chen, P.-S., & Chuang, D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120188 · Cited by 557 · see citing works

Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis

Rossi, A. G., Sawatzky, D. A., Walker, A., Ward, C., Sheldrake, T. A., Riley, N. A., Caldicott, A., Martínez‐Losa, M., Walker, T. R., Duffin, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1468 · Cited by 506 · see citing works

Microglial activation correlates with severity in Huntington disease: A clinical and PET study

Pavese, N., Gerhard, A., Tai, Y. F., Ho, A. K., Turkheimer, F., Barker, R. A., Brooks, D. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000222734.56412.17 · Cited by 462 · see citing works

Neuroprotective Effects of Phenylbutyrate in the N171-82Q Transgenic Mouse Model of Huntington's Disease

Gárdián, G., Browne, S. E., Choi, D., Klivènyi, P., Gregorio, J., Kubilus, J. K., Ryu, H., Langley, B. C., Ratan, R. R., Ferrante, R. J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410210200 · Cited by 456 · see citing works

Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction

Ren, M., Leng, Y., Jeong, M. R., Leeds, P. R., & Chuang, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02406.x · Cited by 378 · see citing works

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes

Chen, P.-S., Peng, G.-S., Li, G., Yang, S., Wu, X., Wang, C. C., Wilson, B. C., Lu, R.-B., Gean, P.-W., Chuang, D.-M., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001893 · Cited by 352 · see citing works

Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation

Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 4× · see citing works

Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis.

Camelo, S. I., Iglesias, A. H., Hwang, D., Due, B., Ryu, H., Smith, K., Gray, S., Imitola, J., Durán, G., Assaf, B., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.02.022 · Cited by 281 · see citing works

Regulation of microglial inflammatory response by sodium butyrate and short‐chain fatty acids

Huuskonen, J., Suuronen, T., Nuutinen, T., Kyrylenko, S., & Salminen, A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705682 · Cited by 274 · see citing works

Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy

Minamiyama, M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh131 · Cited by 260 · see citing works

Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

Blanchard, F., & Chipoy, C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03309-4 · Cited by 241 · see citing works

Endogenous α-Synuclein Is Induced by Valproic Acid through Histone Deacetylase Inhibition and Participates in Neuroprotection against Glutamate-Induced Excitotoxicity

Leng, Y., & Chuang, D. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0096-06.2006 · Cited by 188 · see citing works

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia

Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 170 · see citing works

Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis

Petri, S., Kiaei, M., Kipiani, K., Chen, J., Calingasan, N. Y., Crow, J. P., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.09.013 · Cited by 161 · see citing works

The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses

Moreira, J. M. A., Scheipers, P., & Sørensen, P. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-30 · Cited by 143 · see citing works

Microglial Phagocytosis of Apoptotic Inflammatory T Cells Leads to Down-Regulation of Microglial Immune Activation

Magnus, T., Chan, A., Grauer, O. M., Toyka, K. V., & Gold, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5004 · Cited by 141 · see citing works

Downregulation of lipopolysaccharide response in drosophila by negative crosstalk between the AP1 and NF-κB signaling modules

Kim, T. I., Yoon, J., Cho, H., Lee, W., Kim, J., Song, Y.-H., Kim, S. N., Yoon, J. H., Kim‐Ha, J., & Kim, Y.-J. (2005) · Nature Immunology · doi:10.1038/ni1159 · Cited by 126 · see citing works

Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition

Jeong, M. R., Hashimoto, R., Senatorov, V. V., Fujimaki, K., Ren, M., Lee, M. S., & Chuang, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00350-8 · Cited by 124 · see citing works

Linear Relationship of Valproate Serum Concentration to Response and Optimal Serum Levels for Acute Mania

Allen, M. H., Hirschfeld, R. M. A., Wozniak, P. J., Baker, J. D., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.272 · Cited by 124 · see citing works

Regulation of microglial inflammatory response by histone deacetylase inhibitors

Suuronen, T., Huuskonen, J., Pihlaja, R., Kyrylenko, S., & Salminen, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02004.x · Cited by 122 · see citing works

Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons

Kanai, H., Sawa, A., Chen, R.-W., Leeds, P. R., & Chuang, D. M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500269 · Cited by 120 · see citing works

Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis

Dou, H., Birusingh, K., Faraci, J., Gorantla, S., Poluektova, L. Y., Maggirwar, S. B., Dewhurst, S., Gelbard, H. A., & Gendelman, H. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09162.2003 · Cited by 120 · see citing works

Phagocytosis of Apoptotic Cells by Macrophages Induces Novel Signaling Events Leading to Cytokine-Independent Survival and Inhibition of Proliferation: Activation of Akt and Inhibition of Extracellular Signal-Regulated Kinases 1 and 2

Reddy, S. M., Hsiao, K.-C., Abernethy, V. E., Fan, H., Longacre, A., Lieberthal, W., Rauch, J., Koh, J. S., & Levine, J. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.702 · Cited by 110 · see citing works

Neuroprotective Effects of Phenylbutyrate Against MPTP Neurotoxicity

Gárdián, G., Yang, L., Cléren, C., Calingasan, N. Y., Klivènyi, P., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:235 · Cited by 107 · see citing works

T-helper types 1, 2, and 3 cytokine interactions in symptomatic manic patients.

Kim, Y.-K., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, S.-W., Leonard, B. E., & Steinbusch, H. W. M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.08.005 · Cited by 100 · see citing works

Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: Termination of CNS autoimmune inflammation and modulation by interferon‐beta

Chan, A., Seguin, R. M., Magnus, T., Papadimitriou, C., Toyka, K. V., Antel, J. P., & Gold, R. (2003) · Glia · doi:10.1002/glia.10258 · Cited by 74 · see citing works

Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia

Elsisi, N. S., Darling‐Reed, S., Lee, E.-S., Oriaku, E. T., & Soliman, K. F. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.10.087 · Cited by 71 · see citing works

New method to detect histone acetylation levels by flow cytometry

Ronzoni, S., Faretta, M., Ballarini, M., Pelicci, P. G., & Minucci, S. (2005) · Cytometry Part A · doi:10.1002/cyto.a.20151 · Cited by 66 · see citing works

Valproic acid induces caspase 3-mediated apoptosis in microglial cells

Dragunow, M., Greenwood, J. M., Cameron, R. E., Narayan, P. J., O’Carroll, S. J., Pearson, A. G., & Gibbons, H. M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.065 · Cited by 66 · see citing works

CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity

Neuman, M. G., Shear, N. H., Jacobson-Brown, P., Katz, G. G., Neilson, H. K., Malkiewicz, I. M., Cameron, R., & Abbott, F. S. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00217-x · Cited by 63 · see citing works

Repression of interferon-γ-induced inducible nitric oxide synthase (iNOS) gene expression in microglia by sodium butyrate is mediated through specific inhibition of ERK signaling pathways

Park, J., Woo, M.-S., Kim, S. Y., Kim, W.-K., & Kim, H.-S. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.003 · Cited by 63 · see citing works

Actions of a Histone Deacetylase Inhibitor NSC3852 (5-Nitroso-8-quinolinol) Link Reactive Oxygen Species to Cell Differentiation and Apoptosis in MCF-7 Human Mammary Tumor Cells

Martirosyan, A., Leonard, S. S., Shi, X., Griffith, B. N., Gannett, P. M., & Strobl, J. S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.096891 · Cited by 62 · see citing works

Activity and expression of progesterone metabolizing 5α-reductase, 20α-hydroxysteroid oxidoreductase and 3α(β)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells

Wiebe, J. P., & Lewis, M. J. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-9 · Cited by 57 · see citing works

Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia

Kim, H.-S., Whang, S.-Y., Woo, M.-S., Park, J., Kim, W.-K., & Han, I. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.02.006 · Cited by 43 · see citing works

Microglial distribution and apoptosis in fetal rat brain

Wang, C.-C., Wu, C., Shieh, J.-Y., & Wen, C.-Y. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00584-9 · Cited by 23 · see citing works

Evidence for Epigenetic Mechanisms That Silence Both Basal and Immune-Stimulated Transcription of the IL-8 Gene

Wen, X., & Wu, G. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7290 · Cited by 23 · see citing works

Untitled work

Nolte (2001) · doi:10.1002/1098-1136(20010101)33:1

Regulation of inflammation by short chain fatty acids

Vinolo, M. A. R., Rodrigues, H. G., Nachbar, R. T., & Curi, R. (2011) · Nutrients · doi:10.3390/nu3100858 · Cited by 1,724 · see citing works

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases

Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381 · see citing works

The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis

Stilling, R. M., van de Wouw, M., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.06.011 · Cited by 891 · see citing works

Multiple roles of HDAC inhibition in neurodegenerative conditions

Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676 · see citing works

The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders

Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594 · see citing works

Valproic acid in pregnancy: how much are we endangering the embryo and fetus?

Ornoy, A. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.02.014 · Cited by 526 · see citing works

Molecular and Therapeutic Potential and Toxicity of Valproic Acid

Chateauvieux, S., Morceau, F., Dicato, M., & Diederich, M. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/479364 · Cited by 526 · see citing works

Microbiome–microglia connections via the gut–brain axis

Abdel-Haq, R., Schlachetzki, J. C. M., Glass, C. K., & Mazmanian, S. K. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180794 · Cited by 471 · see citing works

Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency

Shen, S., Sandoval, J., Swiss, V. A., Li, J., Dupree, J. L., Franklin, R. J. M., & Casaccia‐Bonnefil, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2172 · Cited by 486 · see citing works

Molecular genetics and emerging therapies for retinitis pigmentosa: Basic research and clinical perspectives

Dias, M. F., Joo, K., Kemp, J. A., Fialho, S. L., Silva‐Cunha, A., Woo, S. J., & Kwon, Y. J. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.004 · Cited by 420 · see citing works

Therapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder

Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404 · see citing works

The epigenetics of aging and neurodegeneration

Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381 · see citing works

Epigenetic regulation of gene expression in physiological and pathological brain processes

Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373 · see citing works

Microglia, Lifestyle Stress, and Neurodegeneration

Madore, C., Yin, Z., Leibowitz, J. A., & Butovsky, O. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.003 · Cited by 310 · see citing works

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

Morris, G., Berk, M., Carvalho, A. F., Caso, J. R., Sanz, Y., Walder, K. R., & Maes, M. H. J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0004-2 · Cited by 307 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

The Impact of Systemic Inflammation on Alzheimer’s Disease Pathology

Xie, J., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.796867 · Cited by 324 · see citing works

HDAC inhibitor sodium butyrate-mediated epigenetic regulation enhances neuroprotective function of microglia during ischemic stroke

Patnala, R., Arumugam, T. V., Gupta, N., & Dheen, S. T. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0149-z · Cited by 278 · see citing works

The human side of microglia

Smith, A. M., & Dragunow, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.001 · Cited by 256 · see citing works

Epigenetic mechanisms in Alzheimer's disease

Mastroeni, D., Grover, A., Delvaux, E., Whiteside, C. M., Coleman, P. D., & Rogers, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.017 · Cited by 258 · see citing works

Ageing and neurodegenerative diseases

Hung, C.-W., Chen, Y., Hsieh, W.-L., Chiou, S., & Kao, C.-L. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.006 · Cited by 248 · see citing works

Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection

Monti, B., Polazzi, E., & Contestabile, A. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010095 · Cited by 241 · see citing works

Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach

Krug, A. K., Kolde, R., Gaspar, J. A., Rempel, E., Balmer, N. V., Meganathan, K., Vojnits, K., Baquié, M., Waldmann, T., Enseñat‐Waser, R., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0967-3 · Cited by 228 · see citing works

The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials

Duan, H., Wang, L., Huangfu, M., & Li, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115276 · Cited by 241 · see citing works

Epigenetic targeting of histone deacetylase: Therapeutic potential in Parkinson's disease?

Harrison, I. F., & Dexter, D. T. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.010 · Cited by 227 · see citing works

Effect of fecal microbiota transplantation on neurological restoration in a spinal cord injury mouse model: involvement of brain-gut axis

Jing, Y., Yu, Y., Bai, F., Wang, L., Yang, D., Zhang, C., Qin, C., Yang, M., Zhang, D., Zhu, Y., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01007-y · Cited by 225 · see citing works

Sodium Butyrate Abolishes Lipopolysaccharide-Induced Depression-like Behaviors and Hippocampal Microglial Activation in Mice

Yamawaki, Y., Yoshioka, N., Nozaki, K., Ito, H., Oda, K., Harada, K., Shirawachi, S., Asano, S., Aizawa, H., Yamawaki, S., et al. (2018) · Brain Research · doi:10.1016/j.brainres.2017.12.004 · Cited by 204 · see citing works

Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage

Paiva, I., Pinho, R., Pavlou, M. A., Hennion, M., Wales, P., Schütz, A.-L., Rajput, A., Szegő, É. M., Kerimoglu, C., Gerhardt, E., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx114 · Cited by 185 · see citing works

Valproic Acid is Neuroprotective in the Rotenone Rat Model of Parkinson’s Disease: Involvement of α-Synuclein

Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., & Contestabile, A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9090-5 · Cited by 172 · see citing works

Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders

Grayson, D. R., Kundakovic, M., & Sharma, R. P. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061333 · Cited by 171 · see citing works

Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation

Wu, H.-M., Tzeng, N., Li, Q., Wei, S., Hu, X., Chen, S., Rawls, S. M., Flood, P. M., Hong, J., & Lu, R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.64 · Cited by 174 · see citing works

The effects of butyrate enemas on visceral perception in healthy volunteers

Vanhoutvin, S. A. L. W., Troost, F. J., Kilkens, T. O. C., Lindsey, P. J., Hamer, H. M., Jonkers, D. M. A. E., Venema, K., & Brummer, R. ‐. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01324.x · Cited by 171 · see citing works

Intestinal Microbiota in Patients with Spinal Cord Injury

Gungor, B., Adıgüzel, E., Gürsel, İ., Yılmaz, B., & Gürsel, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145878 · Cited by 170 · see citing works

Epigenetic Control of Sexual Differentiation of the Bed Nucleus of the Stria Terminalis

Murray, E. K., Hien, A., Vries, G. J. D., & Forger, N. G. (2009) · Endocrinology · doi:10.1210/en.2009-0458 · Cited by 166 · see citing works

Histone Deacetylase Inhibitors for Treating a Spectrum of Diseases Not Related to Cancer

Dinarello, C. A., Fossati, G., & Mascagni, P. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00116 · Cited by 160 · see citing works

Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner

Schmidtner, A. K., Slattery, D. A., Gläsner, J., Hiergeist, A., Gryksa, K., Malik, V. A., Hellmann-Regen, J., Heuser, I., Baghai, T. C., Gessner, A., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0556-9 · Cited by 153 · see citing works

Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes

Chabane, N., Zayed, N., Afif, H., Endam, L. M., Benderdour, M., Boileau, C., Martel‐Pelletier, J., Pelletier, J., Duval, N., & Fahmi, H. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.03.009 · Cited by 158 · see citing works

Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation

Kaminska, B., Mota, M., & Pizzi, M. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.026 · Cited by 153 · see citing works

The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats

Park, M. J., & Sohrabji, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0765-6 · Cited by 150 · see citing works

Histone deacetylase (HDAC) inhibitors reduce the glial inflammatory response in vitro and in vivo

Faraco, G., Pittelli, M. G., Cavone, L., Fossati, S., Porcu, M., Mascagni, P., Fossati, G., Moroni, F., & Chiarugi, A. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.019 · Cited by 138 · see citing works

HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats.

Zhang, B., West, E., Van, K. C., Gurkoff, G. G., Zhou, J., Zhang, X.-M., Kozikowski, A., & Lyeth, B. G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.05.085 · Cited by 138 · see citing works

Inflammation in ALS and SMA: Sorting out the good from the evil

Papadimitriou, D. A., Verche, V. L., Jacquier, A., Ikiz, B., Przedborski, S., & Ré, D. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.005 · Cited by 132 · see citing works

HDAC inhibitors and neurodegeneration: At the edge between protection and damage

Dietz, K. C., & Casaccia, P. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.011 · Cited by 126 · see citing works

Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis

Yoo, Y.-E., & Ko, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.003 · Cited by 118 · see citing works

Histone Deacetylases and Mood Disorders: Epigenetic Programming in Gene‐Environment Interactions

Machado‐Vieira, R., Ibrahim, L. A., & Zarate, C. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00203.x · Cited by 119 · see citing works

Tuning acetylation levels with HAT activators: Therapeutic strategy in neurodegenerative diseases

Selvi, B. R., Cassel, J., Kundu, T. K., & Boutillier, A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.012 · Cited by 117 · see citing works

Epigenetic regulation in Parkinson’s disease

Labbé, C., Lorenzo‐Betancor, O., & Ross, O. A. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1590-9 · Cited by 115 · see citing works

Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

Harrison, I. F., Smith, A. D., & Dexter, D. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.037 · Cited by 115 · see citing works

Sodium valproate: an old drug with new roles

Nalivaeva, N. N., Belyaev, N. D., & Turner, A. J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.002 · Cited by 115 · see citing works

Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition

Kidd, S. K., & Schneider, J. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.041 · Cited by 113 · see citing works

Acetyltransferases (HATs) as Targets for Neurological Therapeutics

Schneider‐Anthony, A., Chatterjee, S., Bousiges, O., Selvi, B. R., Swaminathan, A., Cassel, R., Blanc, F., Kundu, T. K., & Boutillier, A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0204-7 · Cited by 108 · see citing works

Microbiota–Host Transgenomic Metabolism, Bioactive Molecules from the Inside

Turroni, S., Brigidi, P., Cavalli, A., & Candela, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00244 · Cited by 107 · see citing works

Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β

Correa, F., Mallard, C. E., Nilsson, M., & Sandberg, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.016 · Cited by 106 · see citing works

Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery

Fessler, E. B., Chibane, F. L., Wang, Z., & Chuang, D. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319280009 · Cited by 105 · see citing works

Long-term effects of early life stress exposure: Role of epigenetic mechanisms

Silberman, D. M., Acosta, G. B., & Zubilete, M. A. Z. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.033 · Cited by 104 · see citing works

Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application

Watkins, C. C., Sawa, A., & Pomper, M. G. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.119 · Cited by 100 · see citing works

Epigenetic regulation of reelin and brain-derived neurotrophic factor genes in long-term potentiation in rat medial prefrontal cortex

Sui, L., Wang, Y., Ju, L.-H., & Chen, M. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.03.007 · Cited by 99 · see citing works

Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: Relevance to autism spectrum disorders

Foley, K. A., MacFabe, D. F., Kavaliers, M., & Ossenkopp, K. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.09.032 · Cited by 96 · see citing works

Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

Kidd, S. K., & Schneider, J. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.010 · Cited by 94 · see citing works

Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic Modalities

Kaidery, N. A., Tarannum, S., & Thomas, B. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0211-8 · Cited by 92 · see citing works

Drugs interfering with mitochondrial disorders

Finsterer, J., & Segall, L. (2009) · Drug and Chemical Toxicology · doi:10.3109/01480540903207076 · Cited by 92 · see citing works

Current trends in protein acetylation analysis

Diallo, I., Seve, M., Cunin, V., Minassian, F., Poisson, J., Michelland, S., & Bourgoin‐Voillard, S. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1559061 · Cited by 91 · see citing works

Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury

Fleiss, B., Nilsson, M. K. L., Blomgren, K., & Mallard, C. E. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-70 · Cited by 88 · see citing works

Valproic acid as a promising agent to combat Alzheimer's disease

Zhang, X., Li, X., & Zhang, H. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.003 · Cited by 83 · see citing works

Valproic acid ameliorates inflammation in experimental autoimmune encephalomyelitis rats

Zhang, Z., Zhang, Z., Wu, Y., & Schluesener, H. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.013 · Cited by 84 · see citing works

Epigenetics in Parkinson’s Disease

Pavlou, M. A. S., & Outeiro, T. F. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_19 · Cited by 81 · see citing works

Epigenetic programming of neurodegenerative diseases by an adverse environment

Babenko, O., Kovalchuk, I., & Metz, G. A. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.038 · Cited by 80 · see citing works

HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.

Kim, H. J., & Chuang, D. (2014) · Europe PMC (PubMed Central) · Cited by 79 · see citing works

The Therapeutic Potential of HDAC Inhibitors in the Treatment of Multiple Sclerosis

Faraco, G., Cavone, L., & Chiarugi, A. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00077 · Cited by 80 · see citing works

Relationship Between Short-chain Fatty Acids and Parkinson’s Disease: A Review from Pathology to Clinic

Duan, W.-X., Wang, F., Liu, J., & Liu, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01123-9 · Cited by 78 · see citing works

Valproic acid improves outcome after rodent spinal cord injury: Potential roles of histone deacetylase inhibition

Lv, L., Sun, Y., Han, X., Xu, C., Tang, Y., & Dong, Q. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.040 · Cited by 76 · see citing works

Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review

Sher, Y. I., Cramer, A. C. M., Ament, A., Lolak, S., & Maldonado, J. R. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.09.008 · Cited by 76 · see citing works

Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats

Shao, A., Wang, Z., Wu, H., Dong, X., Li, Y. H., Tu, S., Tang, J., Zhao, M., Zhang, J., & Hong, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8986-0 · Cited by 74 · see citing works

Putting the ‘HAT’ back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions

Sleiman, S. F., Basso, M., Mahishi, L., Kozikowski, A. P., Donohoe, M. E., Langley, B. C., & Ratan, R. R. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902810345 · Cited by 75 · see citing works

Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia

Ziemka‐Nałęcz, M., Jaworska, J., Sypecka, J., Polowy, R., Filipkowski, R. K., & Zalewska, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0049-2 · Cited by 75 · see citing works

Retinitis Pigmentosa: Review of Current Treatment

Wang, A. L., Knight, D. K., Vu, T.-T. T., & Mehta, M. C. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000256 · Cited by 73 · see citing works

Epigenetics and the Modulation of Neuroinflammation

Garden, G. A. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0207-4 · Cited by 70 · see citing works

Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells

Nahman, S., Belmaker, R., & Azab, A. N. (2011) · Innate Immunity · doi:10.1177/1753425911421512 · Cited by 72 · see citing works

HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells

Wang, Y., Wang, X., Liu, L., & Wang, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.10.037 · Cited by 71 · see citing works

Genome‐Wide Association Study Identifies Risk Loci for Cluster Headache

O’Connor, E., Fourier, C., Ran, C., Sivakumar, P., Liesecke, F., Southgate, L., Harder, A. V. E., Vijfhuizen, L. S., Yip, J., Giffin, N., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26150 · Cited by 70 · see citing works

Infectious diseases, autoantibodies, and autoimmunity

Johnson, D., & Jiang, W. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102962 · Cited by 73 · see citing works

Targeting Histone Deacetylases: A Novel Approach in Parkinson’s Disease

Sharma, S., & Taliyan, R. (2015) · Parkinson s Disease · doi:10.1155/2015/303294 · Cited by 70 · see citing works

Valproic acid attenuates inflammation in experimental autoimmune neuritis

Zhang, Z., Zhang, Z. Y., Fauser, U., & Schluesener, H. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8521-4 · Cited by 68 · see citing works

Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation

Peña‐Altamira, E., Prati, F., Massenzio, F., Virgili, M., Contestabile, A., Bolognesi, M. L., & Monti, B. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1121237 · Cited by 70 · see citing works

Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson's disease: A bench-to-bedside translational approach

Liu, J., Lv, X., Ye, T., Zhao, M., Chen, Z., Zhang, Y., Yang, W., Xie, H., Lü, Z., Chen, L., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.01.010 · Cited by 75 · see citing works

Novel biomolecule lycopene-reduced graphene oxide-silver nanoparticle enhances apoptotic potential of trichostatin A in human ovarian cancer cells (SKOV3)

Zhang, X., Huang, F., Zhang, G., Bai, D.-P., Massimo, D. F., Huang, Y., & Gurunathan, S. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144161 · Cited by 68 · see citing works

Pharmacology of epigenetics in brain disorders

Narayan, P. J., & Dragunow, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67 · see citing works

Spinal cord injury-induced gut dysbiosis influences neurological recovery partly through short-chain fatty acids

Jing, Y., Yang, D., Bai, F., Wang, Q., Zhang, C., Yan, Y., Li, Z., Li, Y., Chen, Z., Li, J., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00466-5 · Cited by 67 · see citing works

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

Berendsen, S., Broekman, M. L. D., Seute, T., Snijders, T. J., van Es, C. A., Vos, F. D., Regli, L., & Robe, P. A. J. T. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.694425 · Cited by 67 · see citing works

Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism

Durham, B. S., Grigg, R., & Wood, I. C. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14144 · Cited by 67 · see citing works

Sodium Butyrate and Indole-3-propionic Acid Prevent the Increase of Cytokines and Kynurenine Levels in LPS-induced Human Primary Astrocytes

Garcez, M., Tan, V., Heng, B., & Guillemin, G. (2020) · International Journal of Tryptophan Research · doi:10.1177/1178646920978404 · Cited by 58 · see citing works

Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases

Teijido, Ó., & Cacabelos, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103199 · Cited by 68 · see citing works

Valproic Acid: A New Candidate of Therapeutic Application for the Acute Central Nervous System Injuries

Chen, S., Wu, H.-J., Klebe, D., Hong, Y., & Zhang, J.-M. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1241-2 · Cited by 63 · see citing works

Central and peripheral regulations mediated by short-chain fatty acids on energy homeostasis

Luo, P., Lednovich, K., Xu, K., Nnyamah, C., Layden, B. T., & Xu, P. (2022) · Translational research · doi:10.1016/j.trsl.2022.06.003 · Cited by 62 · see citing works

Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson’s Disease Are Related to Its Anti-Inflammatory Effects

Lima, F. A. V., Joventino, I. P., Joventino, F. P., de Almeida, A. C., Neves, K. R. T., do Carmo, M. R. S., Leal, L. K. A. M., de Andrade, G. M., & Viana, G. S. D. B. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2379-5 · Cited by 63 · see citing works

Histone deacetylase inhibitors sodium butyrate and valproic acid delay spontaneous cell death in purified rat retinal ganglion cells.

Biermann, J., Boyle, J., Pielen, A., & Lagrèze, W. A. (2011) · PubMed Central · Cited by 62 · see citing works

NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease

Suo, H., Wang, P., Tong, J., Cai, L., Liu, J., Huang, D., Huang, L., Wang, Z., Huang, Y., Xu, J., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.015 · Cited by 62 · see citing works

Histone H3 acetylation in the postmortem Parkinson’s disease primary motor cortex

Gebremedhin, K. G., & Rademacher, D. J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.060 · Cited by 62 · see citing works

Epigenetic mechanisms in the development and maintenance of dopaminergic neurons

van Heesbeen, H. J., Mesman, S., Veenvliet, J. V., & Smidt, M. P. (2013) · Development · doi:10.1242/dev.089359 · Cited by 61 · see citing works

Targeting the blood–brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota, circadian rhythms, and their interplays

Wang, Y., Du, W., Hu, X., Yu, X., Guo, C., Jin, X., & Wang, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.009 · Cited by 56 · see citing works

Histone deacetylase inhibition leads to neuroprotection through regulation on glial function

Wu, X., Li, S., Wu, Q., Peng, Y., Yu, D., Wang, H., Chui, D., & Zhao, J. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-s1-p49 · Cited by 18 · see citing works

Histone deacetylase inhibitors valproic acid and sodium butyrate enhance prostaglandins release in lipopolysaccharide-activated primary microglia

Singh, V., Bhatia, H. S., Kumar, A., de Oliveira, A. C. P., & Fiebich, B. L. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.037 · Cited by 53 · see citing works

Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia

Peng, G.-S., Li, G., Tzeng, N., Chen, P.-S., Chuang, D., Hsu, Y., Yang, S., & Hong, J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.10.021 · Cited by 170 · see citing works

Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons

Kanai, H., Sawa, A., Chen, R.-W., Leeds, P. R., & Chuang, D. M. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500269 · Cited by 120 · see citing works

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

Wu, X., Chen, P. S., Dallas, S., Wilson, B. C., Block, M. L., Wang, C.-C., Kinyamu, H. K., Lu, N. Z., Gao, X., Leng, Y., et al. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009024 · Cited by 314 · see citing works